Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site.

Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Abstract Text:

    hitoshi kusabaHitoshi Kusaba,yoshihiro shibataYoshihiro Shibata,shuji aritaShuji Arita,hiroshi ariyamaHiroshi Ariyama,eishi babaEishi Baba,kenji mitsugiKenji Mitsugi,mine haradaMine Harada,shuji nakanoShuji Nakano,hitoshi kusabaHitoshi Kusaba,yoshihiro shibataYoshihiro Shibata,shuji aritaShuji Arita,hiroshi ariyamaHiroshi Ariyama,eishi babaEishi Baba,kenji mitsugiKenji Mitsugi,mine haradaMine Harada,shuji nakanoShuji Nakano,

    A combination chemotherapy of 5-fluorouracil (5-FU) and cisplatin (CDDP) has demonstrated activities in various malignancies, including head and neck, lung, esophageal, gastric, and pancreatic cancers. We reviewed our experience of 11 patients diagnosed as carcinoma of unknown primary site (CUPS), who were treated with infusional 5-FU and CDDP between January 1998 and December 2005. The median number of cycles administered was three (range: 1-12). All patients had measurable disease. Six partial responses were obtained (response rate: 54.5%, 95% confidence interval: 23.4-83.3%). The median survival time for all patients was 10 mo (range, 2-37 mo). The median time to disease progression was 3 mo (range, 1-6 mo). This regimen was well tolerated, with grade 3-4 neutropenia (two patients), febrile neutropenia (one patient), grade 3 nausea/vomiting (one patient), and grade 3 stomatitis (two patients). Grade 2 leukoencephalopathy was observed in one patient. No treatment-related death was observed. The combination chemotherapy of infusional 5-FU and CDDP was feasible and tolerated with promising activity for CUPS.

    Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Publishing Authors By Initials

    h kusabaH Kusaba,y shibataY Shibata,s aritaS Arita,h ariyamaH Ariyama,e babaE Baba,k mitsugiK Mitsugi,m haradaM Harada,s nakanoS Nakano,h kusabaH Kusaba,y shibataY Shibata,s aritaS Arita,h ariyamaH Ariyama,e babaE Baba,k mitsugiK Mitsugi,m haradaM Harada,s nakanoS Nakano,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Medical oncology (Northwood, London, England)

    VOLUME: 24

    Page Numbers: 259-64

    Journal Abbreviation: Med. Oncol.

    ISSN: 1357-0560

    DAY: 12

    MONTH: 09

    YEAR: 2007

    Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9435512

    Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site.

    AFFILIATION: First Department of Medicine and Department of Bio systemic Science of Medicine, Kyushu University Graduate School of Medicine, Fukuoka, Japan. hkusaba@intmed1.med.kyushu-u.ac.jp

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Med Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News